Dysfunction of cholinergic neurotransmission has been implicated in neurological disorders such as Alzheimer's disease, and attempts have been made to use cognitive enhancer such as acetylcholinesterase inhibitors to combat dementia (43–45). Here, ACHE is linked to early-onset autosomal dominant Alzheimer disease.